Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 31.5.2023Zentiva, k.s. (ZNT-1)81777Valzap 160 mg (tbl flm 84x160 mg (blis.PVC/PE/PVDC/Al))31.5.2023R
 31.5.2023Zentiva, k.s. (ZNT-1)84766Rosucard 40 mg filmom obalené tablety (tbl flm 30x40 mg (blis.OPA/Al/PVC/Al))31.5.2023R
 31.5.2023Zentiva, k.s. (ZNT-1)87162Tezeo 80 mg (tbl 90x80 mg (blis.OPA/Al/PVC/Al))31.5.2023R
 31.5.2023Zentiva, k.s. (ZNT-1)9996DLevosimendan Zentiva (con inf 1x5 ml/12,5 mg (liek.skl.inj.))31.5.2023R
 31.5.2023MEDOCHEMIE Ltd. (MOE)0332BCONVERIDE 300 mg/12,5 mg (tbl flm 28x300 mg/12,5 mg (blis.PVC/PVDCAl-nepriehľ.))1.6.2023O
 31.5.2023MEDOCHEMIE Ltd. (MOE)33522MEDOCLAV 625 mg (tbl flm 21x625 mg (blis.Al/PVC))1.6.2023R
 31.5.2023MEDOCHEMIE Ltd. (MOE)37109ARKETIS 30 mg (tbl 30x30 mg (blis.PVC/Al))1.6.2023R
 31.5.2023MEDOCHEMIE Ltd. (MOE)39164MEDOCLAV 1 g (tbl flm 14x1 g (blis.Al/PVC))1.6.2023R
 31.5.2023MEDOCHEMIE Ltd. (MOE)40203KLERIMED 500 mg (tbl flm 14x500 mg (blis.PVC/PVDC/Al))1.6.2023O
 31.5.2023MEDOCHEMIE Ltd. (MOE)4031CDinarex 1,5 mg/ml sirup (sir 1x200 ml (fľ.skl.hnedá s Al viečkom+odmer.lyž.))1.6.2023O
 31.5.2023MEDOCHEMIE Ltd. (MOE)41152MEDOCLAV FORTE 312,5 mg (plv sus 1x100 ml (fľ.skl.jantárová))1.6.2023R
 31.5.2023MEDOCHEMIE Ltd. (MOE)46245MEDOTRIGIN 100 mg (tbl 100x100 mg)1.6.2023O
 31.5.2023MEDOCHEMIE Ltd. (MOE)5243BAXETINE 500 mg (tbl flm 10x500 mg (blis.Al/Al))1.6.2023O
 31.5.2023MEDOCHEMIE Ltd. (MOE)65114MEDOCLAV 1,2 g (plo ijf 100x1,2 g (liek.inj.skl.))1.6.2023O
 31.5.2023Teva B.V. (TEV-NL-4)05158Olanzapin Actavis 5 mg filmom obalené tablety (tbl flm 28x5 mg (blis.Al/Al))15.8.2023R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)